Pronóstico del mercado de servicios de pruebas genéticas de América del Sur y Central hasta 2030 – Análisis regional – por tipo de servicio (pruebas predictivas, pruebas de portadores, pruebas prenatales, pruebas de detección de recién nacidos y otros), enfermedad (cáncer, enfermedades metabólicas, enfermedades cardiovasculares y otras enfermedades), y Proveedor de Servicios (Laboratorios Hospitalarios, Laboratorios de Diagnóstico y Otros)
Mercados emergentes sin explotar en países en desarrollo impulsan el mercado de servicios de pruebas genéticas de América Central y del Sur
Países emergentes como China, India, Brasil y México ofrecen importantes oportunidades de crecimiento a los actores del mercado. El alto crecimiento se puede atribuir en gran medida al creciente gasto público en atención sanitaria, la mejora de la infraestructura sanitaria y la presencia de una gran población de pacientes objetivo. La necesidad de pruebas genéticas también ha aumentado debido a una mayor conciencia sobre los trastornos genéticos en las economías en desarrollo y su diagnóstico temprano. La calidad y disponibilidad de los servicios genéticos pueden diferir entre los países de ingresos altos y los países de ingresos bajos a medianos. La facilidad y aplicabilidad de los procedimientos de pruebas genéticas han beneficiado las actividades de I+D en las regiones en desarrollo de todo el mundo. Los principales actores del mercado se están centrando en estrategias e iniciativas, como acuerdos, colaboraciones, asociaciones y expansiones, para mejorar la disponibilidad, accesibilidad y redes de distribución de sus productos en estos países, ya que les ayudará a abordar la creciente necesidad de diagnóstico y tratamiento tempranos. . Por ejemplo, en 2019, GENOMIKA, uno de los laboratorios de pruebas genéticas líderes en Brasil, llegó a un acuerdo con Veritas para incorporar a su portafolio la Secuenciación Completa del Genoma y todos los servicios asociados a estas pruebas en el campo de la medicina preventiva y la genética clínica. Por lo tanto, se espera que los mercados emergentes en los países en desarrollo ofrezcan importantes oportunidades a los actores que operan en el mercado e impulsen el crecimiento del mercado durante el período previsto.
Descripción general del mercado de servicios de pruebas genéticas de América del Sur y Central
El mercado de servicios de pruebas genéticas de América del Sur y Central está segmentado en Brasil, Argentina y el resto de América del Sur y Central. Se espera que la creciente prevalencia de enfermedades genéticas, la creciente demanda de medicamentos personalizados y pruebas genéticas, y los crecientes avances tecnológicos y lanzamientos de productos aumenten el crecimiento del mercado.
Ingresos y pronóstico del mercado de servicios de pruebas genéticas de América del Sur y Central hasta 2030 (millones de dólares estadounidenses)
Segmentación del mercado de servicios de pruebas genéticas de América del Sur y Central
América del Sur y Central El mercado de servicios de pruebas genéticas se clasifica en tipo de servicio, enfermedad, proveedor de servicios y país.
Según el tipo de servicio, el mercado de servicios de pruebas genéticas de América del Sur y Central está segmentado en pruebas predictivas, pruebas de portadores, pruebas prenatales, pruebas de detección de recién nacidos y otras. El segmento de pruebas predictivas tuvo la mayor participación de mercado en 2022.
En términos de enfermedades, el mercado de servicios de pruebas genéticas de América del Sur y Central se clasifica en cáncer, enfermedades metabólicas, enfermedades cardiovasculares y otras enfermedades. El segmento del cáncer tuvo la mayor participación de mercado en 2022.
Por proveedor de servicios, el mercado de servicios de pruebas genéticas de América del Sur y Central se segmenta en laboratorios hospitalarios, laboratorios de diagnóstico y otros. El segmento de laboratorios hospitalarios tuvo la mayor participación de mercado en 2022.
Por país, el mercado de servicios de pruebas genéticas de América del Sur y Central está segmentado en Brasil, Argentina y el resto de América del Sur y Central. Brasil dominó la cuota de mercado de servicios de pruebas genéticas de América del Sur y Central en 2022.
Eurofins Scientific SE, Laboratory Corp of America Holdings, Quest Diagnostics Inc, Illumina Inc, F. Hoffmann-La Roche Ltd y NeoGenomics Inc son entre las empresas líderes que operan en el mercado de servicios de pruebas genéticas de América del Sur y Central.
Table of Content
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. South & Central America Genetic Testing Services Market - Key Industry Dynamics
4.1 Key Market Drivers
4.1.1 Rising Prevalence of Genetic Diseases
4.1.2 Increasing Awareness and Acceptance of Personalized Medicines
4.1.3 Growing Preference for Direct-To-Consumer (DTC) Genetic Testing
4.2 Market Restraints
4.2.1 Social and Ethical Implications of Genetic Testing
4.2.2 Affordability of Genetic Services
4.3 Market Opportunities
4.3.1 Untapped Emerging Markets in Developing Countries
4.4 Future Trends
4.4.1 Artificial Intelligence-Powered Genetic Testing
4.5 Impact Analysis:
5. Genetic Testing Services Market - South & Central America Market Analysis
5.1 South & Central America Genetic Testing Services Market Revenue (US$ Mn), 2022 - 2030
6. South & Central America Genetic Testing Services Market - Revenue and Forecast to 2030 - by Service Type
6.1 Overview
6.2 South & Central America Genetic Testing Services Market Revenue Share, by Service Type, 2022 & 2030 (%)
6.3 Predictive Testing
6.3.1 Overview
6.3.2 Predictive Testing: South & Central America Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
6.4 Carrier Testing
6.4.1 Overview
6.4.2 Carrier Testing: South & Central America Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
6.5 Prenatal Testing
6.5.1 Overview
6.5.2 Prenatal Testing: South & Central America Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
6.6 Newborn Screening
6.6.1 Overview
6.6.2 Newborn Screening: South & Central America Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
6.7 Others
6.7.1 Overview
6.7.2 Others: South & Central America Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
7. South & Central America Genetic Testing Services Market - Revenue and Forecast to 2030 - by Disease
7.1 Overview
7.2 South & Central America Genetic Testing Services Market Revenue Share, by Disease, 2022 & 2030 (%)
7.3 Cancer
7.3.1 Overview
7.3.2 Cancer: South & Central America Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Cardiovascular Diseases
7.4.1 Overview
7.4.2 Cardiovascular Diseases: South & Central America Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
7.5 Metabolic Diseases
7.5.1 Overview
7.5.2 Metabolic Diseases: South & Central America Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
7.6 Other Diseases
7.6.1 Overview
7.6.2 Other Diseases: South & Central America Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
8. South & Central America Genetic Testing Services Market - Revenue and Forecast to 2030 - by Service Provider
8.1 Overview
8.2 South & Central America Genetic Testing Services Market Revenue Share, by Service Provider, 2022 & 2030 (%)
8.3 Hospital-Based Laboratories
8.3.1 Overview
8.3.2 Hospital-Based Laboratories: South & Central America Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Diagnostic Laboratories
8.4.1 Overview
8.4.2 Diagnostic Laboratories: South & Central America Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
8.5 Others
8.5.1 Overview
8.5.2 Others: South & Central America Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
9. South & Central America Genetic Testing Services Market - Country Analysis
9.1 South & Central America
9.1.1 South & Central America Genetic Testing Services Market, by Country
9.1.1.1 Brazil
9.1.1.1.1 Overview
9.1.1.1.2 Brazil Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
9.1.1.1.3 Brazil Genetic Testing Services Market, by Service Type, 2020-2030 (US$ Million)
9.1.1.1.4 Brazil Genetic Testing Services Market, by Disease, 2020-2030 (US$ Million)
9.1.1.1.5 Brazil Genetic Testing Services Market, by Service Provider, 2020-2030 (US$ Million)
9.1.1.2 Argentina
9.1.1.2.1 Overview
9.1.1.2.2 Argentina Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
9.1.1.2.3 Argentina Genetic Testing Services Market, by Service Type, 2020-2030 (US$ Million)
9.1.1.2.4 Argentina Genetic Testing Services Market, by Disease, 2020-2030 (US$ Million)
9.1.1.2.5 Argentina Genetic Testing Services Market, by Service Provider, 2020-2030 (US$ Million)
9.1.1.3 Rest of South & Central America
9.1.1.3.1 Overview
9.1.1.3.2 Rest of South & Central America Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
9.1.1.3.3 Rest of South & Central America Genetic Testing Services Market, by Service Type, 2020-2030 (US$ Million)
9.1.1.3.4 Rest of South & Central America Genetic Testing Services Market, by Disease, 2020-2030 (US$ Million)
9.1.1.3.5 Rest of South & Central America Genetic Testing Services Market, by Service Provider, 2020-2030 (US$ Million)
10. Genetic Testing Services Market-Industry Landscape
10.1 Overview
10.2 Growth Strategies in Genetic Testing Services Market
10.3 Organic Growth Strategies
10.3.1 Overview
10.4 Inorganic Growth Strategies
10.4.1 Overview
11. Company Profiles
11.1 Eurofins Scientific SE
11.1.1 Key Facts
11.1.2 Business Description
11.1.3 Products and Services
11.1.4 Financial Overview
11.1.5 SWOT Analysis
11.1.6 Key Developments
11.2 Laboratory Corp of America Holdings
11.2.1 Key Facts
11.2.2 Business Description
11.2.3 Products and Services
11.2.4 Financial Overview
11.2.5 SWOT Analysis
11.2.6 Key Developments
11.3 Quest Diagnostics Inc
11.3.1 Key Facts
11.3.2 Business Description
11.3.3 Products and Services
11.3.4 Financial Overview
11.3.5 SWOT Analysis
11.3.6 Key Developments
11.4 Illumina Inc
11.4.1 Key Facts
11.4.2 Business Description
11.4.3 Products and Services
11.4.4 Financial Overview
11.4.5 SWOT Analysis
11.4.6 Key Developments
11.5 F. Hoffmann-La Roche Ltd
11.5.1 Key Facts
11.5.2 Business Description
11.5.3 Products and Services
11.5.4 Financial Overview
11.5.5 SWOT Analysis
11.5.6 Key Developments
11.6 NeoGenomics Inc
11.6.1 Key Facts
11.6.2 Business Description
11.6.3 Products and Services
11.6.4 Financial Overview
11.6.5 SWOT Analysis
11.6.6 Key Developments
12. Appendix
12.1 About Us
12.2 Glossary of Terms
List of Tables
Table 1. South & Central America Genetic Testing Services Market Segmentation
Table 2. Brazil Genetic Testing Services Market, by Service Type - Revenue and Forecast to 2030 (US$ Million)
Table 3. Brazil Genetic Testing Services Market, by Disease - Revenue and Forecast to 2030 (US$ Million)
Table 4. Brazil Genetic Testing Services Market, by Service Provider - Revenue and Forecast to 2030 (US$ Million)
Table 5. Argentina Genetic Testing Services Market, by Service Type - Revenue and Forecast to 2030 (US$ Million)
Table 6. Argentina Genetic Testing Services Market, by Disease - Revenue and Forecast to 2030 (US$ Million)
Table 7. Argentina Genetic Testing Services Market, by Service Provider - Revenue and Forecast to 2030 (US$ Million)
Table 8. Rest of South & Central America Genetic Testing Services Market, by Service Type - Revenue and Forecast to 2030 (US$ Million)
Table 9. Rest of South & Central America Genetic Testing Services Market, by Disease - Revenue and Forecast to 2030 (US$ Million)
Table 10. Rest of South & Central America Genetic Testing Services Market, by Service Provider - Revenue and Forecast to 2030 (US$ Million)
Table 11. Recent Organic Growth Strategies in Genetic Testing Services Market
Table 12. Recent Inorganic Growth Strategies in the Genetic Testing Services Market
Table 13. Glossary of Terms, Genetic Testing Services Market
List of Figures
Figure 1. South & Central America Genetic Testing Services Market Segmentation, By Country
Figure 2. South & Central America Genetic Testing Services Market - Key Industry Dynamics
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. South & Central America Genetic Testing Services Market Revenue (US$ Mn), 2022 - 2030
Figure 5. South & Central America Genetic Testing Services Market Revenue Share, by Service Type, 2022 & 2030 (%)
Figure 6. Predictive Testing: South & Central America Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
Figure 7. Carrier Testing: South & Central America Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
Figure 8. Prenatal Testing: South & Central America Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
Figure 9. Newborn Screening: South & Central America Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
Figure 10. Others: South & Central America Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
Figure 11. South & Central America Genetic Testing Services Market Revenue Share, by Disease, 2022 & 2030 (%)
Figure 12. Cancer: South & Central America Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
Figure 13. Cardiovascular Diseases: South & Central America Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
Figure 14. Metabolic Diseases: South & Central America Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
Figure 15. Other Diseases: South & Central America Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
Figure 16. South & Central America Genetic Testing Services Market Revenue Share, by Service Provider, 2022 & 2030 (%)
Figure 17. Hospital-Based Laboratories: South & Central America Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
Figure 18. Diagnostic Laboratories: South & Central America Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
Figure 19. Others: South & Central America Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
Figure 20. South & Central America Genetic Testing Services Market, by Key Country - Revenue, 2022 (US$ Million)
Figure 21. South & Central America Genetic Testing Services Market, By Key Countries, 2022 and 2030 (%)
Figure 22. Brazil Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
Figure 23. Argentina Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
Figure 24. Rest of South & Central America Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
Figure 25. Growth Strategies in Genetic Testing Services Market
1. Eurofins Scientific SE
2. Laboratory Corp of America Holdings
3. Quest Diagnostics Inc
4. Illumina Inc
5. F. Hoffmann-La Roche Ltd
6. NeoGenomics Inc
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the South & Central America genetic testing services market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the South & Central America genetic testing services market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth South & Central America market trends and outlook coupled with the factors driving the South & Central America genetic testing services market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.